Breaking News Instant updates and real-time market news.

DOC

Physicians Realty Trust

$17.90 /

-0.415 (-2.27%)

, WELL

Welltower

$88.12 /

-1.56 (-1.74%)

07:18
05/19/22
05/19
07:18
05/19/22
07:18

Physicians Realty Trust downgraded to Underperform from Neutral at BofA

BofA analyst Joshua Dennerlein downgraded Physicians Realty Trust (DOC) to Underperform from Neutral with an unchanged price target of $18. His model assumes lower growth going forward given rising interest rates, which are a headwind given that the majority of Physicians Realty's earnings growth is driven by net acquisitions. In addition, Welltower's (WELL) recent bid for Healthcare Realty Trust (HR) suggests little upside versus his net asset value estimate, Dennerlein added.

DOC

Physicians Realty Trust

$17.90 /

-0.415 (-2.27%)

WELL

Welltower

$88.12 /

-1.56 (-1.74%)

HR

Healthcare Realty Trust

$28.04 /

-0.51 (-1.79%)

  • 23

    May

OTHER BREAKING NEWS FROM THE FLY

Downgrade
TerrAscend downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:30
08/12/22
08/12
07:30
08/12/22
07:30
TRSSF

TerrAscend

$2.40 /

+0.11 (+4.80%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

07/22/22 Seaport Global
TerrAscend initiated with a Buy at Seaport Global
02/09/22 Clarus
TerrAscend price target lowered to C$14 from C$16.25 at Clarus
12/08/21 Cantor Fitzgerald
TerrAscend price target raised to $7.65 from $6.70 at Cantor Fitzgerald
11/17/21 Stifel
TerrAscend price target lowered to C$21 from C$23 at Stifel
TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

Downgrade
NextNav cut to Perform at Oppenheimer on capital needs » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
NN

NextNav

$3.39 /

+0.02 (+0.59%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NN NextNav
$3.39 /

+0.02 (+0.59%)

NN NextNav
$3.39 /

+0.02 (+0.59%)

06:32 Today Oppenheimer
NextNav downgraded to Perform from Outperform at Oppenheimer
05/16/22 R.F. Lafferty
NextNav price target lowered to $15 from $16 at R.F. Lafferty
05/13/22 B. Riley
NextNav price target lowered to $14.25 from $17 at B. Riley
01/06/22 R.F. Lafferty
NextNav initiated with a Buy at R.F. Lafferty
NN NextNav
$3.39 /

+0.02 (+0.59%)

Recommendations
Toast price target raised to $27 from $21 at Needham » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
TOST

Toast

$18.12 /

-0.33 (-1.79%)

Needham analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOST Toast
$18.12 /

-0.33 (-1.79%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

07:17 Today KeyBanc
Toast price target raised to $25 from $18 at KeyBanc
05/17/22 Mizuho
Toast price target lowered to $18 from $19 at Mizuho
05/13/22 Needham
Toast price target lowered to $21 from $38 at Needham
05/13/22 Canaccord
Toast price target lowered to $25 from $34 at Canaccord
TOST Toast
$18.12 /

-0.33 (-1.79%)

  • 22
    Sep
TOST Toast
$18.12 /

-0.33 (-1.79%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

Recommendations
Nkarta price target lowered to $38 from $60 at Cantor Fitzgerald » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
NKTX

Nkarta

$15.59 /

-0.36 (-2.26%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

07/28/22 Needham
Nkarta initiated with a Buy at Needham
07/18/22 SVB Securities
Nkarta initiated with an Outperform at SVB Securities
04/26/22 Stifel
Nkarta's AML/NHL data 'a positive' for CAR-NK space, says Stifel
04/25/22 Cantor Fitzgerald
Nkarta assumed with an Overweight at Cantor Fitzgerald
NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

  • 26
    Apr
NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

Initiation
Mereo BioPharma initiated with an Overweight at Cantor Fitzgerald » 07:27
08/12/22
08/12
07:27
08/12/22
07:27
MREO

Mereo BioPharma

$1.15 /

-0.055 (-4.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

06/06/22 Needham
Mereo BioPharma price target lowered to $5 from $10 at Needham
MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

Recommendations
Shattuck Labs price target lowered to $21 from $31 at Needham » 07:26
08/12/22
08/12
07:26
08/12/22
07:26
STTK

Shattuck Labs

$3.68 /

-0.15 (-3.92%)

Needham analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

06/01/22 Citi
Shattuck Labs initiated with a Buy at Citi
05/02/22 H.C. Wainwright
Shattuck Labs initiated with a Buy at H.C. Wainwright
STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

Downgrade
Lennar downgraded to Neutral from Outperform at Wedbush » 07:25
08/12/22
08/12
07:25
08/12/22
07:25
LEN

Lennar

$87.78 /

+0.47 (+0.54%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

06:32 Today Wedbush
Lennar downgraded to Neutral from Outperform at Wedbush
07/12/22 JPMorgan
JPMorgan 'cautious and less constructive' on homebuilders, downgrades Lennar
07/12/22 JPMorgan
Lennar downgraded to Neutral from Overweight at JPMorgan
06/22/22 UBS
Lennar price target lowered to $106 from $108 at UBS
LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

Hot Stocks
GreenLight Bioscences announces $109M financing » 07:25
08/12/22
08/12
07:25
08/12/22
07:25
GRNA

GreenLight Bioscences

$4.00 /

+0.09 (+2.30%)

GreenLight Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRNA GreenLight Bioscences
$4.00 /

+0.09 (+2.30%)

Hot Stocks
ARC Group says RM2 continues to experience 'record demand' for BLOCKPal pallets » 07:22
08/12/22
08/12
07:22
08/12/22
07:22
ARCW

ARC Group

$1.00 /

+ (+0.00%)

ARC Group Worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Aptinyx announces NYX-2925 study did not achieve primary endpoint » 07:22
08/12/22
08/12
07:22
08/12/22
07:22
APTX

Aptinyx

/

+

Aptinyx announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTX Aptinyx
/

+

APTX Aptinyx
/

+

05/18/22 Piper Sandler
Aptinyx price target lowered to $6 from $10 at Piper Sandler
04/14/22 H.C. Wainwright
Aptinyx price target lowered to $2 from $8 at H.C. Wainwright
04/08/22 BMO Capital
Aptinyx price target lowered to $6 from $12 at BMO Capital
04/08/22 Truist
Aptinyx price target lowered to $5 from $12 at Truist
APTX Aptinyx
/

+

APTX Aptinyx
/

+

Hot Stocks
Unity: UBX1325 injection led to clinically meaningful improvement in mean BCVA » 07:20
08/12/22
08/12
07:20
08/12/22
07:20
UBX

Unity Biotechnology

/

+

UNITY Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Downgrade
Diebold downgraded to Underweight from Neutral at JPMorgan » 07:20
08/12/22
08/12
07:20
08/12/22
07:20
DBD

Diebold

$4.46 /

-0.13 (-2.83%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBD Diebold
$4.46 /

-0.13 (-2.83%)

DBD Diebold
$4.46 /

-0.13 (-2.83%)

07/08/22 Wedbush
Wedbush upgrades Diebold, sees sales and earnings positioned to improve
07/08/22 Wedbush
Diebold upgraded to Outperform from Neutral at Wedbush
05/10/22 JPMorgan
Diebold downgraded to Neutral at JPMorgan after 'material' guidance cut
05/10/22 JPMorgan
Diebold downgraded to Neutral from Overweight at JPMorgan
DBD Diebold
$4.46 /

-0.13 (-2.83%)

DBD Diebold
$4.46 /

-0.13 (-2.83%)

Downgrade
Plexus downgraded to Underweight from Neutral at JPMorgan » 07:20
08/12/22
08/12
07:20
08/12/22
07:20
PLXS

Plexus

$95.69 /

+0.88 (+0.93%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLXS Plexus
$95.69 /

+0.88 (+0.93%)

PLXS Plexus
$95.69 /

+0.88 (+0.93%)

07/29/22 Needham
Plexus price target raised to $105 from $93 at Needham
07/27/22 Benchmark
Plexus initiated with a Buy at Benchmark
06/07/22 Raymond James
Plexus upgraded to Outperform from Market Perform at Raymond James
01/28/22 Needham
Plexus price target lowered to $90 from $95 at Needham
PLXS Plexus
$95.69 /

+0.88 (+0.93%)

PLXS Plexus
$95.69 /

+0.88 (+0.93%)

Downgrade
Cognex downgraded to Underweight from Neutral at JPMorgan » 07:19
08/12/22
08/12
07:19
08/12/22
07:19
CGNX

Cognex

$48.48 /

+0.54 (+1.13%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGNX Cognex
$48.48 /

+0.54 (+1.13%)

CGNX Cognex
$48.48 /

+0.54 (+1.13%)

08/03/22 Needham
Cognex price target lowered to $50 from $60 at Needham
08/03/22 Cowen
Cognex price target lowered to $55 from $75 at Cowen
08/03/22 Stephens
Cognex downgraded to Equal Weight at Stephens on logistics demand deteriorating
08/03/22 Stephens
Cognex downgraded to Equal Weight from Overweight at Stephens
CGNX Cognex
$48.48 /

+0.54 (+1.13%)

CGNX Cognex
$48.48 /

+0.54 (+1.13%)

Recommendations
Six Flags price target lowered to $28 from $35 at Stifel » 07:18
08/12/22
08/12
07:18
08/12/22
07:18
SIX

Six Flags

$21.12 /

-4.685 (-18.16%)

Stifel analyst Steven…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

05:44 Today KeyBanc
Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2
08/11/22 KeyBanc
Six Flags downgraded to Sector Weight from Overweight at KeyBanc
07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
06/24/22 Stifel
Six Flags price target lowered to $35 from $52 at Stifel
SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

Hot Stocks
Unity Biotechnology announces anticipated milestones » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
UBX

Unity Biotechnology

/

+

UBX1325 24-week safety…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Recommendations
Toast price target raised to $25 from $18 at KeyBanc » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
TOST

Toast

$18.12 /

-0.33 (-1.79%)

KeyBanc analyst Josh Beck…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOST Toast
$18.12 /

-0.33 (-1.79%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

05/17/22 Mizuho
Toast price target lowered to $18 from $19 at Mizuho
05/13/22 Needham
Toast price target lowered to $21 from $38 at Needham
05/13/22 Canaccord
Toast price target lowered to $25 from $34 at Canaccord
05/09/22 Mizuho
Toast price target lowered to $19 from $23 at Mizuho
TOST Toast
$18.12 /

-0.33 (-1.79%)

  • 22
    Sep
TOST Toast
$18.12 /

-0.33 (-1.79%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

Hot Stocks
PLx Pharma announces survey data on VAZALORE 81 mg » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
PLXP

PLx Pharma

$2.59 /

+0.015 (+0.58%)

PLx Pharma, with its lead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
12/07/21 Raymond James
Raymond James upgrades PLx Pharma on 'compelling entry point'
12/07/21 Raymond James
PLx Pharma upgraded to Outperform from Market Perform at Raymond James
11/12/21 JMP Securities
PLx Pharma reported strong quarter for Vazalore, says JMP Securities
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

Hot Stocks
Unity Biotechnology expects cash to fund operations through 1Q23 » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
UBX

Unity Biotechnology

/

+

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Recommendations
Illumina price target lowered to $300 from $480 at Stifel » 07:16
08/12/22
08/12
07:16
08/12/22
07:16
ILMN

Illumina

$227.64 /

+0.44 (+0.19%)

Stifel analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

06:59 Today Citi
Illumina price target lowered to $200 from $220 at Citi
06:36 Today Baird
Illumina price target lowered to $215 from $306 at Baird
08/11/22 Piper Sandler
Illumina miss 'surprising' given backlog, says Piper Sandler
07/14/22 Canaccord
Illumina merger challenge not reflection of merits, says Canaccord
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

Earnings
Unity Biotechnology reports Q2 EPS (19c) vs. (32c) last year » 07:16
08/12/22
08/12
07:16
08/12/22
07:16
UBX

Unity Biotechnology

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Recommendations
CS Disco price target lowered to $30 from $40 at Stifel » 07:15
08/12/22
08/12
07:15
08/12/22
07:15
LAW

CS Disco

$28.96 /

+0.39 (+1.37%)

Stifel analyst J. Parker…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

06:15 Today BofA
CS Disco downgraded to Neutral from Buy at BofA
06:05 Today Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
05:40 Today Cowen
Cowen cuts CS Disco to Market Perform as momentum hits 'big snag'
05:35 Today Cowen
CS Disco downgraded to Market Perform from Outperform at Cowen
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

  • 15
    Sep
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

Earnings
Real Good Food raises FY22 revenue $155M-$160M from $150M-$160M » 07:15
08/12/22
08/12
07:15
08/12/22
07:15
RGF

Real Good Food

$6.93 /

-0.11 (-1.56%)

FY22 revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

03/08/22 Roth Capital
Real Good Food initiated with a Buy at Roth Capital
11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Jefferies
Jefferies starts Real Good Food at Buy, sees 75% upside in 12 months
11/30/21 Truist
Real Good Food initiated with a Buy at Truist
RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

  • 05
    Nov
General news
Market Update: » 07:15
08/12/22
08/12
07:15
08/12/22
07:15
$ECON

Economic Data

/

+

Market Update: Stock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Venus Concept sees 2022 revenue $110M-$113M, consensus $126.82M » 07:14
08/12/22
08/12
07:14
08/12/22
07:14
VERO

Venus Concept

/

+

The Company now expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERO Venus Concept
/

+

VERO Venus Concept
/

+

06/24/22 BTIG
Venus Concept price target lowered to $5.50 from $7.00 at BTIG
11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
VERO Venus Concept
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.